Julio Montaner

49.1k total citations · 7 hit papers
755 papers, 35.8k citations indexed

About

Julio Montaner is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Julio Montaner has authored 755 papers receiving a total of 35.8k indexed citations (citations by other indexed papers that have themselves been cited), including 577 papers in Infectious Diseases, 462 papers in Epidemiology and 285 papers in Virology. Recurrent topics in Julio Montaner's work include HIV/AIDS Research and Interventions (502 papers), HIV, Drug Use, Sexual Risk (395 papers) and HIV Research and Treatment (285 papers). Julio Montaner is often cited by papers focused on HIV/AIDS Research and Interventions (502 papers), HIV, Drug Use, Sexual Risk (395 papers) and HIV Research and Treatment (285 papers). Julio Montaner collaborates with scholars based in Canada, United States and United Kingdom. Julio Montaner's co-authors include Evan Wood, Thomas Kerr, Robert S. Hogg, Mark Tyndall, Benita Yip, Michael V. O’Shaughnessy, Viviane D. Lima, P. Richard Harrigan, Martin T. Schechter and Kathy Li and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Julio Montaner

739 papers receiving 34.5k citations

Hit Papers

Development of a simple noninvasive index to predict sign... 1997 2026 2006 2016 2006 1998 1998 2010 2002 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julio Montaner Canada 87 20.9k 20.7k 10.1k 5.7k 5.5k 755 35.8k
Robert S. Hogg Canada 81 20.2k 1.0× 12.1k 0.6× 9.2k 0.9× 2.1k 0.4× 5.3k 1.0× 599 27.0k
Evan Wood Canada 85 12.0k 0.6× 20.6k 1.0× 3.4k 0.3× 11.3k 2.0× 6.4k 1.2× 694 28.6k
Steffanie A. Strathdee United States 91 17.0k 0.8× 26.2k 1.3× 2.8k 0.3× 6.4k 1.1× 6.8k 1.2× 773 34.7k
Kenneth H. Mayer United States 102 29.8k 1.4× 21.5k 1.0× 7.1k 0.7× 2.5k 0.4× 12.0k 2.2× 1.2k 43.6k
Richard D. Moore United States 93 16.3k 0.8× 12.3k 0.6× 6.4k 0.6× 1.7k 0.3× 3.4k 0.6× 635 30.6k
John Kaldor Australia 83 8.6k 0.4× 13.7k 0.7× 2.9k 0.3× 3.2k 0.5× 3.7k 0.7× 712 28.0k
David R. Bangsberg United States 97 23.5k 1.1× 11.1k 0.5× 7.4k 0.7× 2.0k 0.4× 12.3k 2.2× 473 31.9k
Thomas Kerr Canada 84 9.4k 0.5× 21.1k 1.0× 1.9k 0.2× 11.8k 2.1× 6.9k 1.2× 725 28.1k
Amy C. Justice United States 81 10.5k 0.5× 8.7k 0.4× 4.0k 0.4× 1.9k 0.3× 2.9k 0.5× 508 23.5k
Marie‐Louise Newell United Kingdom 72 13.9k 0.7× 8.2k 0.4× 4.7k 0.5× 1.8k 0.3× 6.2k 1.1× 427 19.8k

Countries citing papers authored by Julio Montaner

Since Specialization
Citations

This map shows the geographic impact of Julio Montaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Montaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Montaner more than expected).

Fields of papers citing papers by Julio Montaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Montaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Montaner. The network helps show where Julio Montaner may publish in the future.

Co-authorship network of co-authors of Julio Montaner

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Montaner. A scholar is included among the top collaborators of Julio Montaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Montaner. Julio Montaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannigan, Ailish, Nandini Krishnan, Sofia Bartlett, et al.. (2025). Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site. BMC Health Services Research. 25(1). 243–243.
2.
Kooij, Katherine W., Wendy Zhang, Megan E. Marziali, et al.. (2025). Life expectancy and mortality among males and females with HIV in British Columbia in 1996–2020: a population-based cohort study. The Lancet Public Health. 10(3). e228–e236.
3.
Omondi, F. Harrison, Natalie N. Kinloch, Hope R. Lapointe, et al.. (2024). Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size. AIDS. 38(8). 1120–1130. 4 indexed citations
4.
Sang, Jordan M., David Moore, Mark Hull, et al.. (2024). Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling study. The Lancet Regional Health - Americas. 33. 100725–100725. 1 indexed citations
5.
Montoya, Vincent, Junine Toy, Sarah Stone, et al.. (2022). Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysis. The Lancet Regional Health - Americas. 16. 100369–100369. 7 indexed citations
6.
Kinloch, Natalie N., Aniqa Shahid, Gordon Ritchie, et al.. (2020). Evaluation of Nasopharyngeal Swab Collection Techniques for Nucleic Acid Recovery and Participant Experience: Recommendations for COVID-19 Diagnostics. Open Forum Infectious Diseases. 7(11). ofaa488–ofaa488. 21 indexed citations
7.
Kinloch, Natalie N., Gordon Ritchie, Chanson J. Brumme, et al.. (2020). Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results. The Journal of Infectious Diseases. 222(6). 899–902. 65 indexed citations
8.
Closson, Kalysha, Thomas L. Patterson, M. Ruth Lavergne, et al.. (2019). The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study. Canadian Journal of Public Health. 110(6). 779–791. 7 indexed citations
9.
Eyawo, Oghenowede, Charles H. Goldsmith, Mark Hull, et al.. (2019). Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis. BMJ Open. 9(9). e025874–e025874. 54 indexed citations
10.
Barker, Brittany, E. D. Adams, Evan Wood, et al.. (2018). Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs. AIDS and Behavior. 23(5). 1258–1266. 8 indexed citations
11.
Poon, Art F. Y., Réka Gustafson, Patricia Daly, et al.. (2016). Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study. The Lancet HIV. 3(5). e231–e238. 135 indexed citations
12.
Montaner, Julio. (2013). Treatment as prevention: toward an AIDS-free generation.. Europe PMC (PubMed Central). 21(3). 110–114. 26 indexed citations
13.
Vàsàrhelyi, Krisztina, et al.. (2013). Changing Risk Behaviours and the HIV Epidemic: A Mathematical Analysis in the Context of Treatment as Prevention. PLoS ONE. 8(5). e62321–e62321. 7 indexed citations
14.
Parashar, Surita, Keith Chan, David J. Milan, et al.. (2013). The impact of unstable housing on emergency department use in a cohort of HIV-positive people in a Canadian setting. AIDS Care. 26(1). 53–64. 10 indexed citations
15.
Hull, Mark, Zunyou Wu, & Julio Montaner. (2012). Optimizing the engagement of care cascade. Current Opinion in HIV and AIDS. 7(6). 579–586. 88 indexed citations
16.
Montaner, Julio. (2003). Challenges of the unmet needs in the treatment-experienced patient.. PubMed. 13(6 Suppl). S5–9. 3 indexed citations
17.
Wood, Evan, Julio Montaner, Keith Chan, et al.. (2002). Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 16(15). 2065–2072. 120 indexed citations
18.
Cornelisse, Peter, Benita Yip, Kevin J.P. Craib, et al.. (2000). The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy. International Journal of STD & AIDS. 11(1). 52–56. 4 indexed citations
19.
Harris, Marianne & Julio Montaner. (2000). Clinical uses of non-nucleoside reverse transcriptase inhibitors. Reviews in Medical Virology. 10(4). 217–229. 31 indexed citations
20.
Pakker, Nadine G., Marijke Roos, Sigrid A. Otto, et al.. (1999). Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. AIDS. 13(2). 203–212. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026